BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37331486)

  • 21. Birt-Hogg-Dubé syndrome: a novel marker of kidney neoplasia.
    Toro JR; Glenn G; Duray P; Darling T; Weirich G; Zbar B; Linehan M; Turner ML
    Arch Dermatol; 1999 Oct; 135(10):1195-202. PubMed ID: 10522666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Are multiple trichodiscomas/fibrofolliculomas the Birt-Hogg-Dubé syndrome?].
    Belousova IE; Shpilyuk RG; Chepushtanova KO; Gorbunov YG; Kazakov DV
    Arkh Patol; 2021; 83(3):45-51. PubMed ID: 34041896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal cancer and pneumothorax risk in Birt-Hogg-Dubé syndrome; an analysis of 115 FLCN mutation carriers from 35 BHD families.
    Houweling AC; Gijezen LM; Jonker MA; van Doorn MB; Oldenburg RA; van Spaendonck-Zwarts KY; Leter EM; van Os TA; van Grieken NC; Jaspars EH; de Jong MM; Bongers EM; Johannesma PC; Postmus PE; van Moorselaar RJ; van Waesberghe JH; Starink TM; van Steensel MA; Gille JJ; Menko FH
    Br J Cancer; 2011 Dec; 105(12):1912-9. PubMed ID: 22146830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluorescent and chromogenic in situ hybridization of CEN17q as a potent useful diagnostic marker for Birt-Hogg-Dubé syndrome-associated chromophobe renal cell carcinomas.
    Kato I; Iribe Y; Nagashima Y; Kuroda N; Tanaka R; Nakatani Y; Hasumi H; Yao M; Furuya M
    Hum Pathol; 2016 Jun; 52():74-82. PubMed ID: 26980015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TFEB and TFE3 drive kidney cystogenesis and tumorigenesis.
    Di Malta C; Zampelli A; Granieri L; Vilardo C; De Cegli R; Cinque L; Nusco E; Pece S; Tosoni D; Sanguedolce F; Sorrentino NC; Merino MJ; Nielsen D; Srinivasan R; Ball MW; Ricketts CJ; Vocke CD; Lang M; Karim B; Lanfrancone L; Schmidt LS; Linehan WM; Ballabio A
    EMBO Mol Med; 2023 May; 15(5):e16877. PubMed ID: 36987696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review of renal tumors associated with Birt-Hogg-Dubé syndrome with focus on clinical and pathobiological aspects.
    Kuroda N; Furuya M; Nagashima Y; Gotohda H; Kawakami F; Moritani S; Ota S; Hora M; Michal M; Hes O; Nakatani Y
    Pol J Pathol; 2014 Jun; 65(2):93-9. PubMed ID: 25119168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early onset renal cell carcinoma in an adolescent girl with germline FLCN exon 5 deletion.
    Schneider M; Dinkelborg K; Xiao X; Chan-Smutko G; Hruska K; Huang D; Sagar P; Harisinghani M; Iliopoulos O
    Fam Cancer; 2018 Jan; 17(1):135-139. PubMed ID: 28623476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Absence of the Birt-Hogg-Dubé gene product is associated with increased hypoxia-inducible factor transcriptional activity and a loss of metabolic flexibility.
    Preston RS; Philp A; Claessens T; Gijezen L; Dydensborg AB; Dunlop EA; Harper KT; Brinkhuizen T; Menko FH; Davies DM; Land SC; Pause A; Baar K; van Steensel MA; Tee AR
    Oncogene; 2011 Mar; 30(10):1159-73. PubMed ID: 21057536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel missense mutation in the folliculin gene associated with the renal tumor-only phenotype of Birt-Hogg-Dubé syndrome.
    Sano T; Fukui T; Makita N; Shimizu K; Kono J; Masui K; Sato T; Goto T; Sawada A; Fujimoto M; Kojima F; Torishima M; Wada T; Furuya M; Ogawa O; Kobayashi T; Akamatsu S
    Cancer Genet; 2022 Aug; 266-267():28-32. PubMed ID: 35691222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel germline mutations in FLCN gene identified in two Chinese patients with Birt-Hogg-Dubé syndrome.
    Li T; Ning X; He Q; Gong K
    Chin J Cancer; 2017 Jan; 36(1):4. PubMed ID: 28069055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical characterization of renal tumors in patients with Birt-Hogg-Dubé syndrome.
    Iribe Y; Kuroda N; Nagashima Y; Yao M; Tanaka R; Gotoda H; Kawakami F; Imamura Y; Nakamura Y; Ando M; Araki A; Matsushima J; Nakatani Y; Furuya M
    Pathol Int; 2015 Mar; 65(3):126-32. PubMed ID: 25597876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benign clear cell "sugar" tumor of the lung in a patient with Birt-Hogg-Dubé syndrome: a case report.
    Gunji-Niitsu Y; Kumasaka T; Kitamura S; Hoshika Y; Hayashi T; Tokuda H; Morita R; Kobayashi E; Mitani K; Kikkawa M; Takahashi K; Seyama K
    BMC Med Genet; 2016 Nov; 17(1):85. PubMed ID: 27871249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Birt-Hogg-Dubé syndrome with a renal angiomyolipoma: further evidence of a relationship between Birt-Hogg-Dubé syndrome and tuberous sclerosis complex.
    Byrne M; Mallipeddi R; Pichert G; Whittaker S
    Australas J Dermatol; 2012 May; 53(2):151-4. PubMed ID: 22571569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Update of penetrance estimates in Birt-Hogg-Dubé syndrome.
    Bruinsma FJ; Dowty JG; Win AK; Goddard LC; Agrawal P; Attina' D; Bissada N; De Luise M; Eisen DB; Furuya M; Gasparre G; Genuardi M; Gerdes AM; Hansen TVO; Houweling AC; Johannesma PC; Lencastre A; Lim D; Lindor NM; Luzzi V; Lynch M; Maffé A; Menko FH; Michels G; Pulido JS; Ryu JH; Sattler EC; Steinlein OK; Tomassetti S; Tucker K; Turchetti D; van de Beek I; van Riel L; van Steensel M; Zenone T; Zompatori M; Walsh J; Bondavalli D; Maher ER; Winship IM;
    J Med Genet; 2023 Apr; 60(4):317-326. PubMed ID: 36849229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Birt-Hogg-Dubé Syndrome: A Review of Dermatological Manifestations and Other Symptoms.
    Tong Y; Schneider JA; Coda AB; Hata TR; Cohen PR
    Am J Clin Dermatol; 2018 Feb; 19(1):87-101. PubMed ID: 28695430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Familial multiple discoid fibromas: a look-alike of Birt-Hogg-Dubé syndrome not linked to the FLCN locus.
    Starink TM; Houweling AC; van Doorn MB; Leter EM; Jaspars EH; van Moorselaar RJ; Postmus PE; Johannesma PC; van Waesberghe JH; Ploeger MH; Kramer MT; Gille JJ; Waisfisz Q; Menko FH
    J Am Acad Dermatol; 2012 Feb; 66(2):259.e1-9. PubMed ID: 21794948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal tumour suppressor function of the Birt-Hogg-Dubé syndrome gene product folliculin.
    Hudon V; Sabourin S; Dydensborg AB; Kottis V; Ghazi A; Paquet M; Crosby K; Pomerleau V; Uetani N; Pause A
    J Med Genet; 2010 Mar; 47(3):182-9. PubMed ID: 19843504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Are lung cysts in renal cell cancer (RCC) patients an indication for FLCN mutation analysis?
    Johannesma PC; Houweling AC; Menko FH; van de Beek I; Reinhard R; Gille JJ; van Waesberghe JT; Thunnissen E; Starink TM; Postmus PE; van Moorselaar RJ
    Fam Cancer; 2016 Apr; 15(2):297-300. PubMed ID: 26603437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Birt-Hogg-Dubé syndrome in a patient with localized fibrofolliculomas and a novel mutation in the FLCN gene.
    Alonso-González J; Rodríguez-Pazos L; Fernández-Redondo V; Vega-Gliemmo A; Toribio J
    Int J Dermatol; 2011 Aug; 50(8):968-71. PubMed ID: 21781069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathology of Birt-Hogg-Dubé syndrome: A special reference of pulmonary manifestations in a Japanese population with a comprehensive analysis and review.
    Furuya M; Nakatani Y
    Pathol Int; 2019 Jan; 69(1):1-12. PubMed ID: 30632664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.